12 research outputs found
PMH30 COSTS ASSOCIATED WITH ANTIPSYCHOTIC MEDICATIONS AT CLINICALLY RECOMMENDED DOSES BASED ON MEDICAID CLAIMS DATA FROM EIGHT STATES
Get PDFCardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis
Full text linkTreatment Patterns And Costs Of Patients With Gastrointestinal Stromal Tumor (Gist) Receiving First-Line Imatinib
No full textComparison of Methods to Identify Stage IIIB or IV Metastatic Lung Cancer Patients from Electronic Medical Records
No full textPMH74 IMPACT OF ALTERNATIVE TREATMENTS ON POST TREATMENT COSTS FOR PATIENTS WITH BIPOLAR DISORDER
No full textTreatment Patterns and Cost of Care for Patients with Gastrointestinal Stromal Tumor (GIST) Treated with Imatinib
No full textPMH75 IMPACT OF ALTERNATIVE TREATMENTS ON POST-TREATMENT COSTS FOR PATIENTS WITH SCHIZOPHRENIA
No full textIncremental burden of type 2 diabetes in patients experiencing cardiovascular hospitalizations
No full textConfirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma
No full textPMH30 COSTS ASSOCIATED WITH ANTIPSYCHOTIC MEDICATIONS AT CLINICALLY RECOMMENDED DOSES BASED ON MEDICAID CLAIMS DATA FROM EIGHT STATES
No full text
